Clinical Trials Arena on MSN
Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours
The trial is conducted at the Mays Cancer Center, part of the University of Texas at San Antonio’s Health Science Center.
Learn which nanocarriers matter now (LNPs, exosomes, polymers) and the key hurdles in biodistribution, safety, CMC, and ...
Immune checkpoint inhibitor (ICI) pneumonitis is a potentially life-threatening immune-related adverse event associated with ICI therapy across various malignancies. ICIs enhance antitumour immunity ...
Institute of Infectious Disease and Molecular Medicine (IDM) have contributed to an international study that shed new light on why humans and animals are so susceptible to contracting tuberculosis (TB ...
Magnetic nanoparticles engineered T cells inside living mice and guided them into solid tumors, achieving over 90% tumor ...
A study reveals that impaired fatty acid oxidation in tumor-infiltrating CD8⁺ T cells leads to toxic lipid peroxidation and ...
Background The pathogenesis of liver fibrosis centres on the activation of hepatic stellate cells (HSCs). Adenosine-to-inosine RNA editing, primarily catalysed by adenosine deaminase acting on RNA1 ...
The tree shrew is a potential mammalian model for preclinical studies, but its immune system is not well understood. In this study, we utilized single-cell RNA sequencing (scRNA-seq) to construct a ...
1Department of Translational Dental Medicine, Boston University Henry M. Goldman School of Dental Medicine, Boston, Massachusetts.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果